Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)

SHA:600329 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 27, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	20,185	22,121	18,246	19,473	11,199	9,068
Market Cap Growth	0.20%	21.24%	-6.30%	73.88%	23.50%	9.97%
Enterprise Value	20,004	20,903	16,178	17,504	9,587	7,890
Last Close Price	29.99	32.36	27.39	28.89	15.90	12.37
PE Ratio	24.79	22.42	21.17	25.32	16.92	14.50
Forward PE	20.33	22.87	22.87	22.87	16.30	15.49
PS Ratio	2.87	2.69	2.21	2.82	1.70	1.30
PB Ratio	3.60	3.33	2.78	2.99	1.88	1.64
P/TBV Ratio	3.90	3.56	2.96	3.16	2.00	1.74
P/FCF Ratio	22.25	40.40	32.05	28.00	23.22	31.28
P/OCF Ratio	20.09	32.13	26.94	22.84	16.68	18.30
EV/Sales Ratio	2.49	2.54	1.96	2.53	1.45	1.13
EV/EBITDA Ratio	21.57	22.63	20.58	24.96	14.51	12.62
EV/EBIT Ratio	25.11	26.15	24.10	29.82	17.40	14.94
EV/FCF Ratio	19.27	38.17	28.42	25.17	19.88	27.22
Debt / Equity Ratio	0.20	0.05	0.04	0.01	0.01	0.01
Debt / EBITDA Ratio	1.38	0.37	0.34	0.06	0.06	0.07
Debt / FCF Ratio	1.24	0.62	0.47	0.06	0.09	0.15
Asset Turnover	0.76	0.81	0.86	0.80	0.82	0.94
Inventory Turnover	2.60	3.09	3.38	2.76	2.61	2.79
Quick Ratio	1.05	1.51	1.71	1.81	1.85	1.54
Current Ratio	1.70	2.03	2.17	2.64	2.59	2.38
Return on Equity (ROE)	14.18%	14.68%	13.37%	12.63%	11.85%	12.01%
Return on Assets (ROA)	4.69%	4.90%	4.37%	4.23%	4.27%	4.42%
Return on Capital (ROIC)	6.63%	7.24%	6.27%	5.85%	5.96%	6.07%
Return on Capital Employed (ROCE)	11.76%	11.42%	9.84%	8.85%	9.00%	9.29%
Earnings Yield	4.62%	4.46%	4.72%	3.95%	5.91%	6.90%
FCF Yield	5.14%	2.48%	3.12%	3.57%	4.31%	3.20%
Dividend Yield	4.27%	3.96%	4.09%	1.73%	1.89%	2.43%
Payout Ratio	106.14%	88.91%	44.96%	30.17%	35.15%	27.71%
Buyback Yield / Dilution	0.51%	0.71%	-0.94%	0.04%	0.37%	-0.37%
Total Shareholder Return	4.77%	4.67%	3.15%	1.77%	2.26%	2.05%

Source: S&P Capital IQ. Standard template. Financial Sources.